People: Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)
20 May 2019
Mr. James Engelhart serves as Chief Financial Officer of Biohaven Pharmaceutical Holding Company Limited. Prior to this, from August 2014 to May 2016, he served as executive director of finance, Americas for Alexion Pharmaceuticals, Inc., and from March 2006 to July 2014, he served as a finance director for Energizer Holdings, Inc. From May 1998 to March 2006, Mr. Engelhart served in increasingly senior finance roles for BMS and held finance roles in R&D Operations and International Operations at Schering-Plough from 1992 to 1998. Mr. Engelhart started his career as an auditor with Coopers & Lybrand LLP from 1986 through 1991. Mr. Engelhart received his B.S. in accounting from Villanova University and is a CPA (inactive).
|Total Annual Compensation, USD||2,497,200|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||13,080|
|Fiscal Year Total, USD||2,510,280|